Annovis Bio Inc (NYSE: ANVS) kicked off on Friday, down -7.51% from the previous trading day, before settling in for the closing price of $2.13. Over the past 52 weeks, ANVS has traded in a range of $1.11-$10.54.
Annual sales at Healthcare sector company slipped by -73.95% over the past five years. While this was happening, its average annual earnings per share was recorded 47.40%. With a float of $16.59 million, this company’s outstanding shares have now reached $19.49 million.
Annovis Bio Inc (ANVS) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Annovis Bio Inc is 14.87%, while institutional ownership is 14.43%.
Annovis Bio Inc (ANVS) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.97 earnings per share (EPS), lower than consensus estimate (set at -0.6) by -0.37. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.22 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 47.40% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 28.77% during the next five years compared to -73.95% drop over the previous five years of trading.
Annovis Bio Inc (NYSE: ANVS) Trading Performance Indicators
Take a look at Annovis Bio Inc’s (ANVS) current performance indicators. Last quarter, stock had a quick ratio of 7.65.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.09, a number that is poised to hit -0.28 in the next quarter and is forecasted to reach -1.19 in one year’s time.
Technical Analysis of Annovis Bio Inc (ANVS)
Annovis Bio Inc (NYSE: ANVS) saw its 5-day average volume 0.3 million, a negative change from its year-to-date volume of 0.42 million. As of the previous 9 days, the stock’s Stochastic %D was 11.96%.
During the past 100 days, Annovis Bio Inc’s (ANVS) raw stochastic average was set at 26.70%, which indicates a significant increase from 14.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1234 in the past 14 days, which was lower than the 0.2083 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.4906, while its 200-day Moving Average is $2.7181. Nevertheless, the first resistance level for the watch stands at $2.1339 in the near term. At $2.2979, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.4257. If the price goes on to break the first support level at $1.8421, it is likely to go to the next support level at $1.7143. Assuming the price breaks the second support level, the third support level stands at $1.5503.
Annovis Bio Inc (NYSE: ANVS) Key Stats
The company with the Market Capitalisation of 38.39 million has total of 19,486K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -24,590 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -6,220 K.
